Ruifang An
No. 277 West Yanta Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.
Journal: American journal of hematology
Published: April 21, 2026
A triplex-readout CRISPR-Cas12a multimodal biosensing platform for point-of-care detection of avian influenza H5N1.
Journal: Journal of hazardous materials
Published: March 19, 2026
Overall survival and long-term safety of olaparib maintenance in patients with platinum-sensitive relapsed ovarian cancer: final analyses of phase III L-MOCA trial.
Journal: Journal of ovarian research
Published: February 10, 2026
Efficacy and Safety of Oteseconazole in Severe Vulvovaginal Candidiasis Categorized by Candida Species and Previous Genital Tract Infection: A Post Hoc Analysis of a Phase 3 Trial.
Journal: Drug design, development and therapy
Published: January 27, 2026
Postmenopausal mixed gestational trophoblastic neoplasia: a case report and review of the literature.
Journal: AME case reports
Published: October 17, 2025
CRISPR-Cas12a-integrated pregnancy test strip biosensors: Visual detection of telomerase and miRNA let-7a in cervical cancer diagnostics.
Journal: Biosensors & bioelectronics
Published: October 09, 2025
DNMT1 reduces cisplatin sensitivity partially through downregulating FOXO3a in ovarian cancer cells.
DNMT1 reduces cisplatin sensitivity partially through downregulating FOXO3a in ovarian cancer cells.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 16, 2025
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.
Journal: Nature communications
Published: May 19, 2025
Downregulation of PGK1 promotes lipid peroxidation and suppresses proliferation in cervical cancer revealed by liquid-liquid phase separation-related gene signature.
Journal: BMC cancer
Published: March 18, 2025
Visual detection of HPV16 using a photoactivatable CRISPR-Cas12 system.
Journal: Chemical communications (Cambridge, England)
Published: February 24, 2025
Last Updated: 09/26/2026